Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Equities

300760

CNE100003G67

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-21 pm EDT 5-day change 1st Jan Change
278.5 CNY +2.63% Intraday chart for Shenzhen Mindray Bio-Medical Electronics Co., Ltd. +0.37% -4.15%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Mindray Says It Is Compliant with International Trade Rules Ahead of EU Probe MT
Nomura Adjusts Shenzhen Mindray Bio-Medical’s Price Target to 441.20 Yuan From 423.39 Yuan, Keeps at Buy MT
Majority of Shenzhen Stock Exchange-Listed Firms Post Profit Growth in 2023 MT
Mindray Bio-Medical to Buy Controlling Stake in Medical Devices Maker For 6.7 Billion Yuan MT
Chinese medical device firm Mindray plans $927 million deal to control APT Medical RE
Mindray Announces Five-Year Agreement with Wakemed Health & Hospitals CI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Implements Profit Distribution for Third Quarter of 2023, Payable on 22 November 2023 CI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Profit Distribution Plan for Third Quarter 2023 CI
Listed Shenzhen Firms Post 7% Drop in Profit, 4% Rise in Revenue in January-September Period MT
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Proposes Cash Dividend for the Third Quarter of 2023 CI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 423.39 Yuan From 476.95 Yuan, Keeps at Buy MT
Shenzhen Stock Exchange Launches SZSE 50 Index MT
Mindray Bio-Medical’s H1 Profit Jumps Nearly 22%; Revenue Misses Estimate MT
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Chinese healthcare stocks hit by stepped up anti-graft crackdown RE
Mindray Bio-Medical to Buy 75% of German In-Vitro Diagnostics Firm DiaSys For 145 Million Euros MT
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Cash Dividend for 2022, Payable on 29 May 2023 CI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Board Elections CI
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 476.95 Yuan From 462.72 Yuan, Keeps at Buy MT
Mindray Bio-Medical Logs Double-Digit Earnings Growth in Q1 on Strong Medical Equipment Demand MT
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Mindray Revolutionizes the Way of Using Ultrasound with TE Air, Its First Wireless Handheld Ultrasound System CI
Mindray Introduces New Wearable Patient Monitoring System, Refining Clinician’s Workflow to Track Patient Conditions CI
Chart Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
More charts
Shenzhen Mindray Bio-Medical Electronics Co, Ltd. is one of the worldwide leading suppliers of medical devices and solutions. Products include patient monitoring and life support systems, in vitro diagnostics and medical imaging systems, orthopaedic implants, etc.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
278.5 CNY
Average target price
396.6 CNY
Spread / Average Target
+42.39%
Consensus
  1. Stock Market
  2. Equities
  3. 300760 Stock
  4. News Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  5. Shenzhen Mindray Bio Medical Electronics : Nomura Starts Shenzhen Mindray Bio-Medical Electronics at Buy With 474 Yuan Price Target